These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 25627831)

  • 21. Comorbidity of schizophrenia and galactosemia: effective clozapine treatment with weight gain.
    Haasen C; Lambert M; Yagdiran O; Karow A; Krausz M; Naber D
    Int Clin Psychopharmacol; 2003 Mar; 18(2):113-5. PubMed ID: 12598824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clozapine use in children and adolescents.
    Gogtay N; Rapoport J
    Expert Opin Pharmacother; 2008 Feb; 9(3):459-65. PubMed ID: 18220495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In a randomized placebo-controlled add-on study orlistat significantly reduced clozapine-induced constipation.
    Chukhin E; Takala P; Hakko H; Raidma M; Putkonen H; Räsänen P; Terevnikov V; Stenberg JH; Eronen M; Joffe G
    Int Clin Psychopharmacol; 2013 Mar; 28(2):67-70. PubMed ID: 23187856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatitis associated with metformin used for management of clozapine-related weight gain.
    McFadden M; Gordon A; Leong G; Ward D; Scott JG
    Aust N Z J Psychiatry; 2016 Jul; 50(7):701-2. PubMed ID: 26883571
    [No Abstract]   [Full Text] [Related]  

  • 25. Association of initial antipsychotic response to clozapine and long-term weight gain.
    Bai YM; Lin CC; Chen JY; Lin CY; Su TP; Chou P
    Am J Psychiatry; 2006 Jul; 163(7):1276-9. PubMed ID: 16816235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel antipsychotics: comparison of weight gain liabilities.
    Wirshing DA; Wirshing WC; Kysar L; Berisford MA; Goldstein D; Pashdag J; Mintz J; Marder SR
    J Clin Psychiatry; 1999 Jun; 60(6):358-63. PubMed ID: 10401912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.
    Newcomer JW
    CNS Drugs; 2005; 19 Suppl 1():1-93. PubMed ID: 15998156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain.
    Reynolds GP; Zhang Z; Zhang X
    Am J Psychiatry; 2003 Apr; 160(4):677-9. PubMed ID: 12668355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clozapine versus typical neuroleptic medication for schizophrenia.
    Wahlbeck K; Cheine M; Essali MA
    Cochrane Database Syst Rev; 2000; (2):CD000059. PubMed ID: 10796289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of adjunctive treatments added to olanzapine or clozapine for weight control in patients with schizophrenia: a systematic review and meta-analysis.
    Choi YJ
    ScientificWorldJournal; 2015; 2015():970730. PubMed ID: 25664341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain.
    Basile VS; Masellis M; De Luca V; Meltzer HY; Kennedy JL
    Lancet; 2002 Nov; 360(9347):1790-1. PubMed ID: 12480467
    [No Abstract]   [Full Text] [Related]  

  • 32. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.
    Chakos M; Lieberman J; Hoffman E; Bradford D; Sheitman B
    Am J Psychiatry; 2001 Apr; 158(4):518-26. PubMed ID: 11282684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of antipsychotic drugs: focus on therapeutic and adverse effects.
    Werner FM; Coveñas R
    Expert Opin Drug Saf; 2014 Aug; 13(8):1031-42. PubMed ID: 24975932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antipsychotic induced weight gain in schizophrenia:mechanisms and management.
    Rege S
    Aust N Z J Psychiatry; 2008 May; 42(5):369-81. PubMed ID: 18473255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological interventions for clozapine-induced sinus tachycardia.
    Lally J; Docherty MJ; MacCabe JH
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD011566. PubMed ID: 27277334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antipsychotic-induced weight gain: a comprehensive research synthesis.
    Allison DB; Mentore JL; Heo M; Chandler LP; Cappelleri JC; Infante MC; Weiden PJ
    Am J Psychiatry; 1999 Nov; 156(11):1686-96. PubMed ID: 10553730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
    Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
    JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain.
    Cooper GD; Harrold JA; Halford JC; Goudie AJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):428-36. PubMed ID: 17933447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of metformin to control clozapine-associated weight gain in an adolescent with schizoaffective disorder.
    Weaver LA; De León DD; Borgmann-Winter K; Coffey BJ
    J Child Adolesc Psychopharmacol; 2010 Apr; 20(2):153-7. PubMed ID: 20415612
    [No Abstract]   [Full Text] [Related]  

  • 40. Weight changes during clozapine treatment.
    Briffa D; Meehan T
    Aust N Z J Psychiatry; 1998 Oct; 32(5):718-21. PubMed ID: 9805596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.